| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |